Evidence mapPaperPMID 42538124Full record

ReviewChemMedChem2026

Chemical Optimization of Temporin A-L Peptides: From Native Isoforms to Enhanced Antimicrobial Analogs.

Ida Boccino, Paolo Grieco, Francesco Merlino

Abstract readReview
In one paragraph

Review in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ida BoccinoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0009-0002-6662-007X
Paolo GriecoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0002-6854-8123
Francesco MerlinoDepartment of Pharmacy, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0002-9607-229X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temporins A-L, a family of short antimicrobial peptides isolated from the skin secretions of Rana temporaria, have emerged as promising scaffolds for the development of novel anti-infective agents. However, their therapeutic translation is limited by issues such as modest selectivity, susceptibility to proteolytic degradation, and variable potency. In this review, we provide an overview of the medicinal chemistry efforts devoted to the optimization of this class of AMPs through systematic chemical modifications. Strategies including backbone alterations (e.g., D-amino acid incorporation and retro-inverso design), side chain modulation, charge tuning, hydrophobicity adjustment, and the introduction of noncanonical residues are discussed in relation to their impact on antimicrobial activity and selectivity. Particular attention is given to conformationally constrained analogs, such as cyclic, stapled, and bicyclic derivatives, which often display enhanced stability and bioactivity. By integrating available data, we delineated key structure-activity relationships governing temporin function and identified emerging design principles for the development of improved analogs. Finally, current challenges and future perspectives for the advancement of temporin-based therapeutics in medicinal chemistry are outlined.

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesProteinsAmino Acid SequenceAnimalsBacteriaHumansProtein IsoformsStructure-Activity RelationshipAnti-Infective AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesProtein IsoformsProteinstemporintemporin L, Rana temporariaantimicrobial peptides (AMPs)membrane‐active peptidessequence modificationsstructure–activity relationship (SAR)temporins

Identifiers

PMID42538124
PMCPMC13427625

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.